Viewing Study NCT00369161


Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2026-01-31 @ 3:56 PM
Study NCT ID: NCT00369161
Status: COMPLETED
Last Update Posted: 2017-03-03
First Post: 2006-08-25
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Transplantation View
Keywords: